Paper39645617
Canagliflozin differentially modulates carfilzomib-induced endoplasmic reticulum stress in multiple myeloma and endothelial cells.
Dabour MS and 3 others. Arch Toxicol, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Canagliflozin differentially modulates carfilzomib-induced endoplasmic reticulum stress in multiple myeloma and endothelial cells. Papers, record 39645617. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39645617
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Canagliflozin differentially modulates carfilzomib-induced endoplasmic reticulum stress in multiple myeloma and endothelial cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endoplasmic Reticulum Stress | Major topic |
| Canagliflozin | Major topic |
| Multiple Myeloma | Major topic |
| Oligopeptides | Major topic |
| Endothelial Cells | Major topic |
| Sodium-Glucose Transporter 2 Inhibitors | Major topic |
| Proteasome Inhibitors | Major topic |
| Humans | |
| Autophagy | |
| Cell Line, Tumor | |
| Apoptosis | |
| Human Umbilical Vein Endothelial Cells |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| SURRGE | College of Pharmacy, University of Minnesota | PubMed |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31765717 | New generation drugs for treatment of multiple myeloma. | Drug Discov Today | 2020 | https://conductscience.org/library/papers/31765717 | PubMed |
| 2 | 37046991 | Autophagy: A Potential Therapeutic Target to Tackle Drug Resistance in Multiple Myeloma. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37046991 | PubMed |
| 3 | 34728604 | A gene toolbox for monitoring autophagy transcription. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34728604 | PubMed |
| 4 | 38844625 | ATF4 inhibits tumor development and mediates p-GCN2/ASNS upregulation in colon cancer. | Sci Rep | 2024 | https://conductscience.org/library/papers/38844625 | PubMed |
| 5 | 37247463 | Canagliflozin mitigates carfilzomib-induced endothelial apoptosis via an AMPK-dependent pathway. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37247463 | PubMed |
| 6 | 38774006 | The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors: JACC: CardioOncology State-of-the-Art Review. | JACC CardioOncol | 2024 | https://conductscience.org/library/papers/38774006 | PubMed |
| 7 | 38591121 | Carfilzomib activates ER stress and JNK/p38 MAPK signaling to promote apoptosis in hepatocellular carcinoma cells. | Acta Biochim Biophys Sin (Shanghai) | 2024 | https://conductscience.org/library/papers/38591121 | PubMed |
| 8 | 25331550 | Autophagy as a pro-death pathway. | Immunol Cell Biol | 2015 | https://conductscience.org/library/papers/25331550 | PubMed |
| 9 | 38929110 | Empagliflozin Alleviates Carfilzomib-Induced Cardiotoxicity in Mice by Modulating Oxidative Stress, Inflammatory Response, Endoplasmic Reticulum Stress, and Autophagy. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38929110 | PubMed |
| 10 | 23624402 | ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. | Nat Cell Biol | 2013 | https://conductscience.org/library/papers/23624402 | PubMed |
| 11 | 35379504 | 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | J Am Coll Cardiol | 2022 | https://conductscience.org/library/papers/35379504 | PubMed |
| 12 | 29107536 | The Unfolded Protein Response and Cell Fate Control. | Mol Cell | 2018 | https://conductscience.org/library/papers/29107536 | PubMed |
| 13 | 16418332 | Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. | Blood | 2006 | https://conductscience.org/library/papers/16418332 | PubMed |
| 14 | 24150220 | Induction of differential apoptotic pathways in multiple myeloma cells by class-selective histone deacetylase inhibitors. | Leukemia | 2014 | https://conductscience.org/library/papers/24150220 | PubMed |
| 15 | 30733602 | The proteostasis network and its decline in ageing. | Nat Rev Mol Cell Biol | 2019 | https://conductscience.org/library/papers/30733602 | PubMed |
| 16 | 38608731 | The proteasome inhibitor carfilzomib exerts anti-inflammatory and antithrombotic effects on the endothelium. | J Thromb Haemost | 2024 | https://conductscience.org/library/papers/38608731 | PubMed |
| 17 | 30662442 | The C/EBP Homologous Protein (CHOP) Transcription Factor Functions in Endoplasmic Reticulum Stress-Induced Apoptosis and Microbial Infection. | Front Immunol | 2018 | https://conductscience.org/library/papers/30662442 | PubMed |
| 18 | 31979059 | Proteasome Inhibitors for the Treatment of Multiple Myeloma. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/31979059 | PubMed |
| 19 | 27565383 | Inhibition of autophagy with chloroquine potentiates carfilzomib-induced apoptosis in myeloma cells in vitro and in vivo. | Cancer Lett | 2016 | https://conductscience.org/library/papers/27565383 | PubMed |
| 20 | 34862383 | Amino acid deprivation induces AKT activation by inducing GCN2/ATF4/REDD1 axis. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34862383 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42329290 | Canagliflozin attenuates Parkinson's disease and is associated with modulation of gut-inflammasome-brain axis in rats. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42329290 | PubMed |
| 41562912 | From Glucose Transport to Microbial Modulation: The Impact of Sodium Glucose Co-Transporter-2 Inhibitors on the Gut Microbiota. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/41562912 | PubMed |
| 41360758 | Endoplasmic Reticulum Stress: A Novel Target for the Prevention and Treatment of Hypertension and Its Related Diseases. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/41360758 | PubMed |
| 41283232 | The Gut Microbiome Role in Multiple Myeloma: Emerging Insights and Therapeutic Opportunities. | Hematol Rep | 2025 | https://conductscience.org/library/papers/41283232 | PubMed |
| 40213696 | Carfilzomib in multiple myeloma: unraveling cardiac toxicities - from mechanisms to diagnosis and management. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40213696 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATF4 | 468 | PubTator's text mining | https://conductscience.org/library/genes/468 | NCBI Gene |
| DDIT3 | 1649 | PubTator's text mining | https://conductscience.org/library/genes/1649 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39645617
GET https://conductscience.org/api/papers/v1/39645617/references?page=2